{"id":"W2922256160","doi":"10.1200/jco.2019.37.15_suppl.e16024","title":"First-line PD(L)1 inhibitors for platinum-ineligible advanced urothelial carcinoma (aUC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atezolizumab; Pembrolizumab; Internal medicine; Nivolumab; Durvalumab; Gastroenterology; Oncology; Urology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001039206,0.0001457633,0.0004079756,0.0002589009,0.0002471172,0.0004640633,0.0002628992,0.0002571101,0.003218584],"category_scores_gemma":[0.002361415,0.0001019464,0.000358704,0.0004616544,0.0001985595,0.000335137,0.000364605,0.0004640033,0.0007010725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004660884,"about_ca_system_score_gemma":0.0007023741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003758706,"about_ca_topic_score_gemma":0.001023999,"domain_scores_codex":[0.9995075,0.0001573464,0.00008502389,0.00009170464,0.00009305574,0.00006528266],"domain_scores_gemma":[0.9976608,0.0005543835,0.001168956,0.0001165758,0.0001189448,0.0003803872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006972597,0.0008508323,0.8871358,0.0008106737,0.0002127892,0.0008380277,0.0001408564,0.0004272892,0.003547871,0.0001425464,0.004674658,0.09424601],"study_design_scores_gemma":[0.001446696,0.01126059,0.9488577,0.0002797078,0.0003323681,0.00598536,0.0001543556,0.00102003,0.004867723,0.0001493585,0.02563289,0.00001308553],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878077,0.004980311,0.0005736295,0.0004301152,0.00004157784,0.0002345283,0.002780013,0.000039601,0.003112488],"genre_scores_gemma":[0.9942668,0.001423427,0.0006760902,0.0004134231,0.00007391067,0.0001230071,0.002037138,0.000009054173,0.000977085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003218584,"threshold_uncertainty_score":0.01076728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08396877193433286,"score_gpt":0.4396420499198661,"score_spread":0.3556732779855332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}